Analytical Data
-
Gene name
OSGIN1
- Application
-
Alternative Names
BDGI; OKL38; Bone Marrow Stromal Cell-Derived Growth Inhibitor; Pregnancy Induced Growth Inhibitor; Ovary, kidney and liver protein 38
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UJX0
-
Expression Region
Gly25~Val281
-
Molecular Weight
37kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OSGIN1, or oxidative stress-induced growth inhibitor 1, is a gene that has garnered attention due to its role in cellular responses to oxidative stress, a condition where an imbalance between reactive oxygen species and antioxidant defenses can lead to cellular damage and contribute to various diseases, including cancer and neurodegenerative disorders. Research indicates that OSGIN1 is upregulated in response to oxidative stress, suggesting it may function as a key player in cellular protective mechanisms. Its involvement in regulating cell proliferation, apoptosis, and survival under stress conditions positions OSGIN1 as a potential target for therapeutic interventions. Recent studies have focused on understanding the molecular pathways influenced by OSGIN1, including its interactions with other proteins and signaling pathways that mediate stress responses. Additionally, investigating the expression patterns of OSGIN1 in different tissues and disease states may provide insights into its functional significance and potential as a biomarker. The recombinant expression of OSGIN1 protein has enabled researchers to study its biochemical properties and interactions in vitro, facilitating a deeper understanding of its role in cellular physiology and pathology. Overall, the ongoing research on OSGIN1 holds promise for revealing novel therapeutic strategies to mitigate the effects of oxidative stress-related diseases.
